Acquisition

Halma PLC
20 December 2007




                                   Halma p.l.c.

                              ACQUISITION OF RIESTER

                   Expansion of Halma's Health and Analysis Sector



Halma, the leading safety, health and sensor technology group, announces it has
acquired PP Medizintechnik GmbH and its subsidiaries Rudolf Riester GmbH & Co KG
and Riester Verwaltungs GmbH (collectively 'Riester') from Paragon Secondary
Partners L.P. and G. Glufke for €55 million (£39.3 million) net cash.

Riester, based in Jungingen, Germany, is a leading manufacturer of small
diagnostic medical devices for applications including Ophthalmology, Blood
Pressure measurement and Ear, Nose and Throat diagnostics.  Riester is an
internationally recognised brand and generates over 90% of its revenue outside
of Germany.  The current CEO of Riester, Gerhard Glufke, will remain with the
business.

In the year ended 31 December 2006, Riester's revenues and operating profits
were €19.4 million (£13.9 million) and €5.6 million (£4 million) respectively;
the management accounts for the nine months ended 30 September 2007 indicate
continued growth, with operating profits of €4.6 million (£3.3 million) (note
2).  The acquisition, which is immediately earnings enhancing in the current
financial year, has been funded from Halma's existing cash and debt facilities.

There will be a € for € adjustment to the consideration paid, capped at €2
million (£1.4 million), based on the level of net tangible assets at 31 December
2007, with any adjustment payable by 6 March 2008.



Andrew Williams, Halma's Chief Executive, commented:

'Riester adds new products and sales channels to our existing Health Optics
business, particularly in the medical doctor and practitioner market segment. 
Their geographic footprint is highly complementary with a strong presence in
Spanish speaking territories.  It is an excellent addition to our Health and
Analysis sector where we remain well placed to grow organically and through
further acquisitions.  We welcome the Riester team to Halma.'





For further information please contact:


Halma p.l.c.                                 [phone]
Andrew Williams, Chief Executive
Kevin Thompson, Finance Director


Hogarth Partnership Limited                  [phone]
Rachel Hirst/Andrew Jacques



Notes to editors

1.   A copy of this announcement, together with other information about Halma, 
     may be viewed on its website: www.halma.com


2.   The operating profit figures are stated before goodwill amortisation, 
     interest and non-recurring management fees. In the year ended 31 December 
     2006, these three items totalled €3.3 million (£2.4 million).  Goodwill 
     amortisation, interest and management charges arose as a result of the
     non-trading holding company structure implemented upon PP Medizintechnik 
     GmbH's acquisition of the subsidiaries in 2005.


3.   Riester's gross assets as at 31 December 2006 were €25.8 million 
     (£18.4 million), including €16.1 million (£11.5 million) of goodwill.


4.   This statement is not intended to constitute a profit forecast for the 
     current financial period or any future period.  In addition, this 
     statement should not be taken to mean that the earnings per share of 
     Halma will necessarily match or exceed the historic reported earnings 
     per share of Halma.


5.   Exchange rate used: £1 : €1.40


6.   Forward-looking statements have been made by the Directors in good faith 
     using information available up until the date that they approved this 
     statement.  Forward-looking statements should be regarded with caution 
     because of the inherent uncertainties in economic trends and business
     risks.



                      This information is provided by RNS
            The company news service from the London Stock Exchange